Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   On 23 January 2006, an FDA advisory panel voted 11 to 3 to recommend the approval of an OTC formulation of orlistat, to be sold under the brand name Alli by GlaxoSmithKline. [41] Approval was granted on 7 February 2007, [42] and Alli became the first weight loss drug officially sanctioned by the U.S. government for over-the-counter use. [43]

3. Pfizer moves forward with once-daily weight-loss pill - AOL

   www.aol.com/news/pfizer-moves-forward-once-daily...

   Some analysts expect the weight-loss drug market, currently dominated by Novo Nordisk's Wegovy and Eli Lilly's Zepbound, to be worth more than $150 billion in annual sales by the early 2030s.

4. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Are there other pill forms of GLP-1 for weight loss? In May 2023, Novo Nordisk announced that obese or overweight adults who took a once-daily 50 milligram dose of oral semaglutide for 68 weeks ...

5. This Promising Weight Loss Drug Candidate Could Be a Huge ...

   www.aol.com/promising-weight-loss-drug-candidate...

   This year, the company is projecting between $58.5 billion to $61.5 billion in revenue, which would be at best around 5% growth versus its 2023 sales of $58.5 billion.

6. AOL Mail

   mail.aol.com

   You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.

7. Pfizer Advances Once-Daily Weight-Loss Pill As It ... - AOL

   www.aol.com/finance/pfizer-advances-once-daily...

   July 11, 2024 at 11:45 AM. Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market. On Thursday, Pfizer Inc. (NYSE: PFE) announced that, based on results from the ...